The	DT	the O TermTag
Role	NN	role O TermTag
of	IN	of O TermTag
PPARs	NNS	ppar O TermTag
in	IN	in O TermTag
Lung	NN	lung O TermTag
Fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

Pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
is	VBZ	be O TermTag
a	DT	a dt NUPOS
group	NN	group O TermTag
of	IN	of O TermTag
disorders	NNS	disorder O TermTag
characterized	VBN	characterize O TermTag
by	IN	by O TermTag
accumulation	NN	accumulation O TermTag
of	IN	of O TermTag
scar	NN	scar O TermTag
tissue	NN	tissue O TermTag
in	IN	in O TermTag
the	DT	the O TermTag
lung	NN	lung O TermTag
interstitium	NN	interstitium O TermTag
,	,	, , NUPOS
resulting	VBG	result O TermTag
in	IN	in O TermTag
loss	NN	loss O TermTag
of	IN	of O TermTag
alveolar	JJ	alveolar O TermTag
function	NN	function O TermTag
,	,	, , NUPOS
destruction	NN	destruction O TermTag
of	IN	of O TermTag
normal	JJ	normal O TermTag
lung	NN	lung O TermTag
architecture	NN	architecture O TermTag
,	,	, , NUPOS
and	CC	and O TermTag
respiratory	JJ	respiratory O TermTag
distress	NN	distress O TermTag
.	.	. . NUPOS

Some	DT	some O TermTag
types	NNS	type O TermTag
of	IN	of O TermTag
fibrosis	NN	fibrosis O TermTag
respond	VBP	respond O TermTag
to	TO	to O TermTag
corticosteroids	NNS	corticosteroid O TermTag
,	,	, , NUPOS
but	CC	but O TermTag
for	IN	for O TermTag
many	JJ	many O TermTag
there	EX	there O TermTag
are	VBP	be O TermTag
no	DT	no O TermTag
effective	JJ	effective O TermTag
treatments	NNS	treatment O TermTag
.	.	. . NUPOS

Prognosis	NN	prognosis O TermTag
varies	VBZ	vary O TermTag
but	CC	but O TermTag
can	MD	can O TermTag
be	VB	be O TermTag
poor	JJ	poor O TermTag
.	.	. . NUPOS

For	IN	for O TermTag
example	NN	example O TermTag
,	,	, , NUPOS
patients	NNS	patient O TermTag
with	IN	with O TermTag
idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
(	(	( ( NUPOS
IPF	NN	IPF O TermTag
)	)	) ) NUPOS
have	VBP	have O TermTag
a	DT	a dt NUPOS
median	JJ	median O TermTag
survival	NN	survival O TermTag
of	IN	of O TermTag
only	RB	only O TermTag
2.9	CD	2.9 O TermTag
years	NNS	year O TermTag
.	.	. . NUPOS

Prognosis	NN	prognosis O TermTag
may	MD	may O TermTag
be	VB	be O TermTag
better	RBR	well O TermTag
in	IN	in O TermTag
patients	NNS	patient O TermTag
with	IN	with O TermTag
some	DT	some O TermTag
other	JJ	other O TermTag
types	NNS	type O TermTag
of	IN	of O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
,	,	, , NUPOS
and	CC	and O TermTag
there	EX	there O TermTag
is	VBZ	be O TermTag
variability	NN	variability O TermTag
in	IN	in O TermTag
survival	NN	survival O TermTag
even	RB	even O TermTag
among	IN	among O TermTag
individuals	NNS	individual O TermTag
with	IN	with O TermTag
biopsy-proven	JJ	biopsy-proven O TermTag
IPF	NN	IPF O TermTag
.	.	. . NUPOS

Evidence	NN	evidence O TermTag
is	VBZ	be O TermTag
accumulating	VBG	accumulate O TermTag
that	IN	that O TermTag
the	DT	the O TermTag
peroxisome	NN	peroxisome O TermTag
proliferator-activated	JJ	proliferator-activated O TermTag
receptors	NNS	receptor O TermTag
(	(	( ( NUPOS
PPARs	NNS	ppar O TermTag
)	)	) ) NUPOS
play	VBP	play O TermTag
important	JJ	important O TermTag
roles	NNS	role O TermTag
in	IN	in O TermTag
regulating	VBG	regulate O TermTag
processes	NNS	process O TermTag
related	VBN	relate O TermTag
to	TO	to O TermTag
fibrogenesis	NN	fibrogenesis O TermTag
,	,	, , NUPOS
including	VBG	include O TermTag
cellular	JJ	cellular O TermTag
differentiation	NN	differentiation O TermTag
,	,	, , NUPOS
inflammation	NN	inflammation O TermTag
,	,	, , NUPOS
and	CC	and O TermTag
wound	NN	wound O TermTag
healing	NN	healing O TermTag
.	.	. . NUPOS

PPARalpha	NN	PPARalpha O TermTag
agonists	NNS	agonist O TermTag
,	,	, , NUPOS
including	VBG	include O TermTag
the	DT	the O TermTag
hypolidipemic	JJ	hypolidipemic O TermTag
fibrate	NN	fibrate O TermTag
drugs	NNS	drug O TermTag
,	,	, , NUPOS
inhibit	VBP	inhibit O TermTag
the	DT	the O TermTag
production	NN	production O TermTag
of	IN	of O TermTag
collagen	NN	collagen O TermTag
by	IN	by O TermTag
hepatic	JJ	hepatic O TermTag
stellate	NN	stellate O TermTag
cells	NNS	cell O TermTag
and	CC	and O TermTag
inhibit	VBP	inhibit O TermTag
liver	NN	liver O TermTag
,	,	, , NUPOS
kidney	NN	kidney O TermTag
,	,	, , NUPOS
and	CC	and O TermTag
cardiac	JJ	cardiac O TermTag
fibrosis	NN	fibrosis O TermTag
in	IN	in O TermTag
animal	NN	animal O TermTag
models	NNS	model O TermTag
.	.	. . NUPOS

In	IN	in O TermTag
the	DT	the O TermTag
mouse	NN	mouse O TermTag
model	NN	model O TermTag
of	IN	of O TermTag
lung	NN	lung O TermTag
fibrosis	NN	fibrosis O TermTag
induced	VBN	induce O TermTag
by	IN	by O TermTag
bleomycin	NN	bleomycin O TermTag
,	,	, , NUPOS
a	DT	a dt NUPOS
PPARalpha	NN	PPARalpha O TermTag
agonist	NN	agonist O TermTag
significantly	RB	significant O TermTag
inhibited	VBD	inhibit O TermTag
the	DT	the O TermTag
fibrotic	JJ	fibrotic O TermTag
response	NN	response O TermTag
,	,	, , NUPOS
while	IN	while O TermTag
PPARalpha	NN	PPARalpha O TermTag
knockout	NN	knockout O TermTag
mice	NNS	mouse O TermTag
developed	VBD	develop O TermTag
more	RBR	much O TermTag
serious	JJ	serious O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

PPARbeta/delta	NN	PPARbeta/delta O TermTag
appears	VBZ	appear O TermTag
to	TO	to O TermTag
play	VB	play O TermTag
a	DT	a dt NUPOS
critical	JJ	critical O TermTag
role	NN	role O TermTag
in	IN	in O TermTag
regulating	VBG	regulate O TermTag
the	DT	the O TermTag
transition	NN	transition O TermTag
from	IN	from O TermTag
inflammation	NN	inflammation O TermTag
to	TO	to O TermTag
wound	VB	wind O TermTag
healing	NN	healing O TermTag
.	.	. . NUPOS

PPARbeta/delta	NN	PPARbeta/delta O TermTag
agonists	NNS	agonist O TermTag
inhibit	VBP	inhibit O TermTag
lung	NN	lung O TermTag
fibroblast	NN	fibroblast O TermTag
proliferation	NN	proliferation O TermTag
and	CC	and O TermTag
enhance	VBP	enhance O TermTag
the	DT	the O TermTag
antifibrotic	JJ	antifibrotic O TermTag
properties	NNS	property O TermTag
of	IN	of O TermTag
PPARgamma	NN	PPARgamma O TermTag
agonists	NNS	agonist O TermTag
.	.	. . NUPOS

PPARgamma	NN	PPARgamma O TermTag
ligands	NNS	ligand O TermTag
oppose	VBP	oppose O TermTag
the	DT	the O TermTag
profibrotic	JJ	profibrotic O TermTag
effect	NN	effect O TermTag
of	IN	of O TermTag
TGF-beta	NN	TGF-beta GENE TermTag
,	,	, , NUPOS
which	WDT	which O TermTag
induces	VBZ	induce O TermTag
differentiation	NN	differentiation O TermTag
of	IN	of O TermTag
fibroblasts	NNS	fibroblast O TermTag
to	TO	to O TermTag
myofibroblasts	NNS	myofibroblast O TermTag
,	,	, , NUPOS
a	DT	a dt NUPOS
critical	JJ	critical O TermTag
effector	NN	effector O TermTag
cell	NN	cell O TermTag
in	IN	in O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

PPARgamma	NN	PPARgamma O TermTag
ligands	NNS	ligand O TermTag
,	,	, , NUPOS
including	VBG	include O TermTag
the	DT	the O TermTag
thiazolidinedione	JJ	thiazolidinedione O TermTag
class	NN	class O TermTag
of	IN	of O TermTag
antidiabetic	JJ	antidiabetic O TermTag
drugs	NNS	drug O TermTag
,	,	, , NUPOS
effectively	RB	effective O TermTag
inhibit	VBP	inhibit O TermTag
lung	NN	lung O TermTag
fibrosis	NN	fibrosis O TermTag
in	FW	in O TermTag
vitro	FW	vitro O TermTag
and	CC	and O TermTag
in	IN	in O TermTag
animal	NN	animal O TermTag
models	NNS	model O TermTag
.	.	. . NUPOS

The	DT	the O TermTag
clinical	JJ	clinical O TermTag
availability	NN	availability O TermTag
of	IN	of O TermTag
potent	JJ	potent O TermTag
and	CC	and O TermTag
selective	JJ	selective O TermTag
PPARalpha	NN	PPARalpha O TermTag
and	CC	and O TermTag
PPARgamma	NN	PPARgamma O TermTag
agonists	NNS	agonist O TermTag
should	MD	shall O TermTag
facilitate	VB	facilitate O TermTag
rapid	JJ	rapid O TermTag
development	NN	development O TermTag
of	IN	of O TermTag
successful	JJ	successful O TermTag
treatment	NN	treatment O TermTag
strategies	NNS	strategy O TermTag
based	VBN	base O TermTag
on	IN	on O TermTag
current	JJ	current O TermTag
and	CC	and O TermTag
ongoing	JJ	ongoing O TermTag
research	NN	research O TermTag
.	.	. . NUPOS

